SCHEMBL9979369

SCHEMBL9979369

Cc1csc(-c2cccc(-c3nc(NCc4ccncc4)c4ccncc4n3)c2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LATS1 O95835 11/20 0.51
LATS2 Q9NRM7 9/20 0.51
PDE5A O76074 4/20 0.50
PTGS1 P23219 2/20 0.50
TBXAS1 P24557 2/20 0.50
PTGS2 P35354 2/20 0.50
PRKCH P24723 2/20 0.49
ROCK2 O75116 1/20 0.49
PRKCQ Q04759 1/20 0.49
ROCK1 Q13464 1/20 0.49
PKN1 Q16512 1/20 0.49
PKN2 Q16513 1/20 0.49
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
USP2 O75604 3/20 0.48
LMNA P02545 3/20 0.48
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2D6 P10635 3/20 0.48
TSHR P16473 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9979110 0.80 CYP1A2 (0.52) LATS1LATS2PDE5APTGS1TBXAS1
SCHEMBL9979137 0.79 PDE5A (0.55) LATS1LATS2PDE5APTGS1TBXAS1
SCHEMBL12039897 0.76 CYP1A2 (0.55) LATS1LATS2PDE5APTGS1TBXAS1
SCHEMBL9979245 0.75 IRAK1 (0.45) LATS1LATS2PDE5APTGS1TBXAS1
SCHEMBL9979331 0.74 LATS1 (0.50) LATS1LATS2PDE5APTGS1TBXAS1
SCHEMBL9979316 0.70 CYP1A2 (0.54) LATS1LATS2PDE5APTGS1TBXAS1
SCHEMBL1062736 0.70 PDE5A (0.89) PDE5APTGS1TBXAS1PTGS2MEN1
SCHEMBL20548215 0.69 LATS1 (1.00) LATS1LATS2PRKCHROCK2PRKCQ
SCHEMBL7277479 0.68 PDE5A (1.00) PDE5APTGS1TBXAS1PTGS2MEN1
SCHEMBL13252155 0.68 PDE5A (0.83) PDE5APTGS1TBXAS1PTGS2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110319409-A1 7-AZA-QUINAZOLINE PDE10 INHIBITORS COX CHRISTOPHER D (US) 2011-12-29 US claimed
US-20110319409-A1 7-AZA-QUINAZOLINE PDE10 INHIBITORS COX CHRISTOPHER D (US) 2011-12-29 US disclosed
US-20110319409-A1 7-AZA-QUINAZOLINE PDE10 INHIBITORS COX CHRISTOPHER D (US) 2011-12-29 US disclosed
US-20110319409-A1 7-AZA-QUINAZOLINE PDE10 INHIBITORS COX CHRISTOPHER D (US) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319409-A1 7-AZA-QUINAZOLINE PDE10 INHIBITORS PDE5A, PDE12, PDE7B LATS1 4435/4885LATS2 4167/4885PDE5A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.